•For Kent and Medway Guidance on Inflammatory Bowel Disease (IBD) (Adults) High Cost Drug (HCD) Pathway.
•For Kent and Medway Policy Recommendation on Dual biological therapy for inflammatory bowel disease (IBD) in adults (not routinely funded by Kent and Medway Integrated Care Board)
